COVID-19 advice for people taking steroids

Last updated: 07-24-2020

Read original article here

COVID-19 advice for people taking steroids

Steroids are an important treatment for people with conditions such as arthritis, vasculitis and joint pain. They’re usually taken as tablets or injections into muscles, joints or soft tissues.

It can be dangerous to suddenly stop taking steroids, as they can cause withdrawal symptoms. If you are taking steroid tablets you should carry a steroid alert card. It is important for a healthcare professional to know if you are on steroids and the dose you are taking, in case you suddenly become ill or have an accident.

This information was developed by NHS England and is referred to in the NICE (National Institute of Health and Care Excellence) rapid guidelines for managing rheumatological autoimmune, inflammatory and metabolic bone disorders during the coronavirus outbreak.

It’s been announced that the common arthritis drug, dexamethasone, can help save the lives of people who are seriously ill with COVID-19.

Dexamethasone is a type of corticosteroid, which is commonly used to reduce inflammation in people with inflammatory arthritis or autoimmune conditions like rheumatoid arthritis, lupus and gout.

Research into using this drug to treat coronavirus was conducted as part of the RECOVERY (Randomised Evaluation of COVID-19 Therapy) trial by the University of Oxford to test a range of potential treatments for COVID-19.

Due to the immune-suppressing properties of dexamethasone, researchers decided to test its effectiveness in treating coronavirus patients with severe respiratory symptoms.

Researchers found that dexamethasone reduced deaths by one-third in ventilated patients, and by one fifth in other patients receiving oxygen only. There was no benefit among those patients who did not require respiratory support.

Dexamethasone is a readily accessible drug, and the first that’s shown to improve survival rates in COVID-19.

While it is effective for treating coronavirus patients requiring respiratory support for severe respiratory symptoms, guidelines should still be followed for people taking the drug to treat inflammatory or autoimmune conditions.


Read the rest of this article here